IBDEI0NY ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10657,1,3,0)
 ;;=3^Exudative ARMD,Right Eye (Unspec Stage)
 ;;^UTILITY(U,$J,358.3,10657,1,4,0)
 ;;=4^H35.3210
 ;;^UTILITY(U,$J,358.3,10657,2)
 ;;=^5138520
 ;;^UTILITY(U,$J,358.3,10658,0)
 ;;=H35.3220^^74^687^8
 ;;^UTILITY(U,$J,358.3,10658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10658,1,3,0)
 ;;=3^Exudative ARMD,Left Eye (Unspec Stage)
 ;;^UTILITY(U,$J,358.3,10658,1,4,0)
 ;;=4^H35.3220
 ;;^UTILITY(U,$J,358.3,10658,2)
 ;;=^5138524
 ;;^UTILITY(U,$J,358.3,10659,0)
 ;;=H35.3131^^74^687^4
 ;;^UTILITY(U,$J,358.3,10659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10659,1,3,0)
 ;;=3^Non-Exudative ARMD,Early Dry Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,10659,1,4,0)
 ;;=4^H35.3131
 ;;^UTILITY(U,$J,358.3,10659,2)
 ;;=^5138511
 ;;^UTILITY(U,$J,358.3,10660,0)
 ;;=H35.3130^^74^687^3
 ;;^UTILITY(U,$J,358.3,10660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10660,1,3,0)
 ;;=3^Non-Exudative ARMD,Bilateral (Unspec Stage)
 ;;^UTILITY(U,$J,358.3,10660,1,4,0)
 ;;=4^H35.3130
 ;;^UTILITY(U,$J,358.3,10660,2)
 ;;=^5138510
 ;;^UTILITY(U,$J,358.3,10661,0)
 ;;=H44.2A1^^74^687^37
 ;;^UTILITY(U,$J,358.3,10661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10661,1,3,0)
 ;;=3^Degenerative Myopia w/ CNV,Right Eye
 ;;^UTILITY(U,$J,358.3,10661,1,4,0)
 ;;=4^H44.2A1
 ;;^UTILITY(U,$J,358.3,10661,2)
 ;;=^5151318
 ;;^UTILITY(U,$J,358.3,10662,0)
 ;;=H44.2A2^^74^687^38
 ;;^UTILITY(U,$J,358.3,10662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10662,1,3,0)
 ;;=3^Degenerative Myopia w/ CNV,Left Eye
 ;;^UTILITY(U,$J,358.3,10662,1,4,0)
 ;;=4^H44.2A2
 ;;^UTILITY(U,$J,358.3,10662,2)
 ;;=^5151319
 ;;^UTILITY(U,$J,358.3,10663,0)
 ;;=H44.2A3^^74^687^39
 ;;^UTILITY(U,$J,358.3,10663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10663,1,3,0)
 ;;=3^Degenerative Myopia w/ CNV,Bilateral
 ;;^UTILITY(U,$J,358.3,10663,1,4,0)
 ;;=4^H44.2A3
 ;;^UTILITY(U,$J,358.3,10663,2)
 ;;=^5151320
 ;;^UTILITY(U,$J,358.3,10664,0)
 ;;=H44.2B1^^74^687^40
 ;;^UTILITY(U,$J,358.3,10664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10664,1,3,0)
 ;;=3^Degenerative Myopia w/ Mac Hole,Right Eye
 ;;^UTILITY(U,$J,358.3,10664,1,4,0)
 ;;=4^H44.2B1
 ;;^UTILITY(U,$J,358.3,10664,2)
 ;;=^5151322
 ;;^UTILITY(U,$J,358.3,10665,0)
 ;;=H44.2B2^^74^687^41
 ;;^UTILITY(U,$J,358.3,10665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10665,1,3,0)
 ;;=3^Degenerative Myopia w/ Mac Hole,Left Eye
 ;;^UTILITY(U,$J,358.3,10665,1,4,0)
 ;;=4^H44.2B2
 ;;^UTILITY(U,$J,358.3,10665,2)
 ;;=^5151323
 ;;^UTILITY(U,$J,358.3,10666,0)
 ;;=H35.3133^^74^687^6
 ;;^UTILITY(U,$J,358.3,10666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10666,1,3,0)
 ;;=3^Non-Exudative ARMD, Advanced Atrophic w/o SF, Bilateral
 ;;^UTILITY(U,$J,358.3,10666,1,4,0)
 ;;=4^H35.3133
 ;;^UTILITY(U,$J,358.3,10666,2)
 ;;=^5138513
 ;;^UTILITY(U,$J,358.3,10667,0)
 ;;=H35.3132^^74^687^5
 ;;^UTILITY(U,$J,358.3,10667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10667,1,3,0)
 ;;=3^Non-Exudative ARMD, Intermediate Dry Stage, Bilateral
 ;;^UTILITY(U,$J,358.3,10667,1,4,0)
 ;;=4^H35.3132
 ;;^UTILITY(U,$J,358.3,10667,2)
 ;;=^5138512
 ;;^UTILITY(U,$J,358.3,10668,0)
 ;;=H35.3291^^74^687^9
 ;;^UTILITY(U,$J,358.3,10668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10668,1,3,0)
 ;;=3^Exudative ARMD, w/ Active CNVM, Unspec Eye
 ;;^UTILITY(U,$J,358.3,10668,1,4,0)
 ;;=4^H35.3291
 ;;^UTILITY(U,$J,358.3,10668,2)
 ;;=^5138533
